Radiomics Improves Cancer Screening and Early Detection

Robert J. Gillies, Matthew B. Schabath
2020 Cancer Epidemiology, Biomarkers and Prevention  
Imaging is a key technology in the early detection of cancers, including X-ray mammography, low dose CT for lung cancer, or optical imaging for skin, esophageal, or colorectal cancers. Historically, imaging information in early detection schema was assessed qualitatively. However, the last decade has seen increased development of computerized tools that convert images into quantitative mineable data (radiomics), and their subsequent analyses with artificial intelligence, AI. These tools are
more » ... oving diagnostic accuracy of early lesions to define risk and classify malignant/aggressive from benign/indolent disease. The first section of this review will briefly describe the various imaging modalities and their use as primary or secondary screens in an early detection pipeline. The second section will describe specific use cases to illustrate the breadth of imaging modalities as well as the benefits of quantitative image analytics. These will include optical (skin cancer), X-ray CT (pancreatic and lung cancer), X-ray mammography (breast cancer), multiparametric MRI (breast and prostate cancer), PET (pancreatic cancer), and ultrasound elastography (liver cancer). Finally, we will discuss the inexorable improvements in radiomics to build more robust classifier models, and the significant limitations to this development that include access will well annotated data bases, and biological descriptors of the imaged feature data.
doi:10.1158/1055-9965.epi-20-0075 pmid:32917666 fatcat:36unqm2nrfcqbh7yhqedqz24ua